275 related articles for article (PubMed ID: 36613532)
1. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
[TBL] [Abstract][Full Text] [Related]
2. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy.
Psilopatis I; Souferi-Chronopoulou E; Vrettou K; Troungos C; Theocharis S
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499598
[TBL] [Abstract][Full Text] [Related]
3. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
Psilopatis I; Pergaris A; Vrettou K; Tsourouflis G; Theocharis S
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328669
[TBL] [Abstract][Full Text] [Related]
4. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
5. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
[TBL] [Abstract][Full Text] [Related]
7. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
8. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread.
Pergaris A; Danas E; Goutas D; Sykaras AG; Soranidis A; Theocharis S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445116
[TBL] [Abstract][Full Text] [Related]
10. Ephrin-Eph signaling usage by a variety of viruses.
de Boer ECW; van Gils JM; van Gils MJ
Pharmacol Res; 2020 Sep; 159():105038. PubMed ID: 32565311
[TBL] [Abstract][Full Text] [Related]
11. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
12. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
13. Methylmercury alters Eph and ephrin expression during neuronal differentiation of P19 embryonal carcinoma cells.
Wilson DT; Polunas MA; Zhou R; Halladay AK; Lowndes HE; Reuhl KR
Neurotoxicology; 2005 Aug; 26(4):661-74. PubMed ID: 15990172
[TBL] [Abstract][Full Text] [Related]
14. Comparative 3'UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines.
Winter J; Roepcke S; Krause S; Müller EC; Otto A; Vingron M; Schweiger S
PLoS One; 2008 Jul; 3(7):e2780. PubMed ID: 18648668
[TBL] [Abstract][Full Text] [Related]
15. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
Herath NI; Spanevello MD; Sabesan S; Newton T; Cummings M; Duffy S; Lincoln D; Boyle G; Parsons PG; Boyd AW
BMC Cancer; 2006 Jun; 6():144. PubMed ID: 16737551
[TBL] [Abstract][Full Text] [Related]
17. The first identification of complete Eph-ephrin signalling in ctenophores and sponges reveals a role for neofunctionalization in the emergence of signalling domains.
Krishnan A; Degnan BM; Degnan SM
BMC Evol Biol; 2019 Apr; 19(1):96. PubMed ID: 31023220
[TBL] [Abstract][Full Text] [Related]
18. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
19. The role of Eph receptors and ephrin ligands in colorectal cancer.
Herath NI; Boyd AW
Int J Cancer; 2010 May; 126(9):2003-11. PubMed ID: 20039322
[TBL] [Abstract][Full Text] [Related]
20. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.
Nakamoto M; Bergemann AD
Microsc Res Tech; 2002 Oct; 59(1):58-67. PubMed ID: 12242697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]